相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat
Caitlin A. Jones et al.
PSYCHOPHARMACOLOGY (2011)
Current perspectives on selective dopamine D-3 receptor antagonists as pharmacotherapeutics for addictions and related disorders
Christian A. Heidbreder et al.
ADDICTION REVIEWS 2 (2010)
Metabotropic glutamate mGlu1 receptor stimulation and blockade: Therapeutic opportunities in psychiatric illness
Anne Lesage et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925
Ariel Graff-Guerrero et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures
Mark J. Millan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Behavioral Indices in Antipsychotic Drug Discovery
Roger D. Porsolt et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model
Stefania Risso Bradley et al.
NEUROPHARMACOLOGY (2010)
Cortico-Basal Ganglia Reward Network: Microcircuitry
Susan R. Sesack et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Enhanced cognitive performance of dopamine D3 receptor knock-out mice in the step-through passive-avoidance test: Assessing the role of the endocannabinoid/endovanilloid systems
Vincenzo Micale et al.
PHARMACOLOGICAL RESEARCH (2010)
Chronic fluoxetine differentially modulates the hippocampal microtubular and serotonergic system in grouped and isolation reared rats
Massimiliano Bianchi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Blockade of dopamine D-3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D-1 receptor agonists, but not of D-2 antagonists
Florence Loiseau et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model
Beate Winner et al.
EXPERIMENTAL NEUROLOGY (2009)
Dopaminergic Modulation of Risk-Based Decision Making
Jennifer R. St Onge et al.
NEUROPSYCHOPHARMACOLOGY (2009)
EFFECTS OF SOCIAL ISOLATION REARING ON THE LIMBIC BRAIN: A COMBINED BEHAVIORAL AND MAGNETIC RESONANCE IMAGING VOLUMETRY STUDY IN RATS
M. I. Schubert et al.
NEUROSCIENCE (2009)
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia
Jared W. Young et al.
PHARMACOLOGY & THERAPEUTICS (2009)
H(3) receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing retrieval
Vincent Pascoli et al.
PSYCHOPHARMACOLOGY (2009)
Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task
M. V. King et al.
PSYCHOPHARMACOLOGY (2009)
Fluoxetine Administration Modulates the Cytoskeletal Microtubular System in the Rat Hippocampus
Massimiliano Bianchi et al.
SYNAPSE (2009)
Increased Dopamine D2High Receptors in Rats Reared in Social Isolation
Madeleine V. King et al.
SYNAPSE (2009)
In Vivo Quantification of Regional Dopamine-D3 Receptor Binding Potential of (+)-PHNO: Studies in Non-Human Primates and Transgenic Mice
Eugenii A. Rabiner et al.
SYNAPSE (2009)
Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15
Istvan Gyertyan et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function
Kevin C. F. Fone
NEUROPHARMACOLOGY (2008)
Object recognition memory: Neurobiological mechanisms of encoding, consolidation and retrieval
Boyer D. Winters et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Behavioural and neurochemical effects of post-weaning social isolation in rodents - Relevance to developmental neuropsychiatric disorders
Kevin C. F. Fone et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Cognitive impairment in schizophrenia:: a review of developmental and genetic models, and pro-cognitive profile of the optimised D3 > D2 antagonist, S33138
Mark J. Millan et al.
THERAPIE (2008)
What Does the Anatomical Organization of the Entorhinal Cortex Tell Us?
Cathrin B. Canto et al.
NEURAL PLASTICITY (2008)
S33138 (N-[4-[2-[(3aS, 9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent:: III.: Actions in models of therapeutic activity and induction of side effects
Mark J. Millan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
S33138[N-[4-[2-[(3aS, 9bR)-8-cyano-1,3a, 4,9b-tetrahydro[1]-benzopyrano[3,4-c] pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent:: I.: Receptor-binding profile and functional actions at G-protein-coupled receptors
Mark J. Millan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
S33138[N-[4-[2-[(3aS, 9bR)-8-cyano-1, 3a, 4, 9b-tetrahydro[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent.: II.: A neurochemical, electrophysiological and behavioral characterization in vivo
Mark J. Millan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Multiple variants of the DRD3, but not BDNF gene, influence age-at-onset of schizophrenia
J. Renou et al.
MOLECULAR PSYCHIATRY (2007)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
Richard S. E. Keefe et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
The doparnine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion
Laurel M. Pritchard et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Isolation rearing and hyperlocomotion are associated with reduced immediate early gene expression levels in the medial prefrontal cortex
J. B. Levine et al.
NEUROSCIENCE (2007)
Selective blockade of dopamine D3 versus D2 receptors enhances frontocortical cholinergic transmission and social memory in rats:: a parallel neurochemical and behavioural analysis
Mark J. Millan et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Dopamine D3 receptor agonists for protection and repair in Parkinson's disease
Jeffrey N. Joyce et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents
Ekrem Dere et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus
M. Bianchi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Relative expression of D3 dopamine receptor and alternative splice variant D3nf rnRNA in high and low responders to novelty
Laurel M. Pritchard et al.
BRAIN RESEARCH BULLETIN (2006)
Selective dopamine D3 receptor antagonists enhance cortical acetylcholine levels measured with high-performance liquid chromatography/tandem mass spectrometry without anti-cholinesterases
Laurent P. Lacroix et al.
JOURNAL OF NEUROSCIENCE METHODS (2006)
Psychosis pathways converge via D2High dopamine receptors
Philip Seeman et al.
SYNAPSE (2006)
Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats
Min Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Social isolation selectively reduces hippocampal brain-derived neurotrophic factor without altering plasma corticosterone
S Scaccianoce et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action
K Rutten et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2006)
Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting
SB Floresco et al.
NEUROPSYCHOPHARMACOLOGY (2006)
KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia
WK Park et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonist
J Cilia et al.
PSYCHOPHARMACOLOGY (2005)
Dopamine D3 receptor antagonists as therapeutic agents
JN Joyce et al.
DRUG DISCOVERY TODAY (2005)
Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention
SB Glickstein et al.
CEREBRAL CORTEX (2005)
Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats
J Laszy et al.
PSYCHOPHARMACOLOGY (2005)
Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation
J Prickaerts et al.
PSYCHOPHARMACOLOGY (2005)
5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation - an effect sensitive to NMDA receptor antagonism
MV King et al.
NEUROPHARMACOLOGY (2004)
Selective blockade of D3 dopamine receptors enhances the antiparkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate
MA Silverdale et al.
EXPERIMENTAL NEUROLOGY (2004)
The role of dopamine D3 compared with D2 receptors in the control of locomotor activity:: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats
MJ Millan et al.
PSYCHOPHARMACOLOGY (2004)
Hyperactivity to novelty induced by social isolation is not correlated with changes in D2 receptor function and binding in striatum
A Del Arco et al.
PSYCHOPHARMACOLOGY (2004)
5-ht(6) Receptors
Marie L. Woolley et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2004)
Formulation and evaluation of metronidazole acid gel for vaginal contraception
SA El-Gizawy et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790
ML Woolley et al.
PSYCHOPHARMACOLOGY (2003)
Retrograde and anterograde object recognition in rats with hippocampal lesions
S Gaskin et al.
HIPPOCAMPUS (2003)
Effects of hippocampal lesions on patterned motor learning in the rat
TJ Gould et al.
BRAIN RESEARCH BULLETIN (2002)
SL65.0155, a novel 5-hydroxytryptamine4 receptor partial agonist with potent cognition-enhancing properties
PC Moser et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
D3 dopamine receptor, behavioral sensitization, and psychosis
NM Richtand et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2001)
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
O Guillin et al.
NATURE (2001)
A peripheral marker for schizophrenia:: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes
T Ilani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Intra-accumbens infusion of D3 receptor agonists reduces spontaneous and dopamine-induced locomotion
AM Ouagazzal et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Effects of noradrenaline depletion in the brain on response to novelty in isolation-reared rats
MDS Lapiz et al.
PSYCHOPHARMACOLOGY (2000)
Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients
M Takahashi et al.
MOLECULAR PSYCHIATRY (2000)
Possible implications of the dopamine D-3 receptor in schizophrenia and in antipsychotic drug actions
JC Schwartz et al.
BRAIN RESEARCH REVIEWS (2000)
分享论文
